News by Tag: Global Cancer Market
Japanese Cancer mAbs Market to Post Double-Digit Growth by 2015
February 27, 2013
Japan's cancer mAbs market is likely to post double-digit growth to reach US$ 2.7 Billion by 2015, says RNCOS in its latest research report.
February 27, 2013
Japan's cancer mAbs market is likely to post double-digit growth to reach US$ 2.7 Billion by 2015, says RNCOS in its latest research report.
Antineoplastics mAbs is the Top Therapeutic Class for Cancer Treatment
December 19, 2012
Amongst the several cancer treatments available, antineoplastics mAbs is the top therapeutic class for cancer treatment, says RNCOS.
December 19, 2012
Amongst the several cancer treatments available, antineoplastics mAbs is the top therapeutic class for cancer treatment, says RNCOS.
Cancer Monoclonal Antibodies Market to 2015
August 31, 2012
RNCOS has recently added a new Market Research Report titled, "Cancer Monoclonal Antibodies Market to 2015" to its report gallery. The report provides extensive research on the cancer monoclonal antibodies market.
August 31, 2012
RNCOS has recently added a new Market Research Report titled, "Cancer Monoclonal Antibodies Market to 2015" to its report gallery. The report provides extensive research on the cancer monoclonal antibodies market.
mAbs Dominating Cancer Treatment Market Landscape
March 30, 2012
With proper efficacy in treatment and minimal side effects, monoclonal antibodies are being considered as the leading option for cancer treatment, says RNCOS.
March 30, 2012
With proper efficacy in treatment and minimal side effects, monoclonal antibodies are being considered as the leading option for cancer treatment, says RNCOS.
Rituxan/Mabthera to Maintain the Top Position in Cancer mAbs
March 21, 2012
Despite the entry of biosimilars and stiff competition from other mAbs, Rituxan is likely to maintain its leading position.
March 21, 2012
Despite the entry of biosimilars and stiff competition from other mAbs, Rituxan is likely to maintain its leading position.
Global Cancer Monoclonal Antibodies Market to Continue Growing Strongly
March 19, 2012
The cancer monoclonal antibodies (mAbs) market has been expanding across the globe as novel mAbs deliver effective treatments to patients, acknowledges RNCOS.
March 19, 2012
The cancer monoclonal antibodies (mAbs) market has been expanding across the globe as novel mAbs deliver effective treatments to patients, acknowledges RNCOS.